Top

Reactions Weekly

Published in:

01-01-2023 | Cutaneous Squamous Cell Carcinoma | Case report

Cemiplimab

Pruritus, fatigue and worsening hypothyroidism: 2 case reports

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Pabianek M, et al. Promising Immune Treatment of Advanced Cutaneous Squamous Cell Carcinoma with Cemiplimab-Real-World Experience in the Global SARS-CoV-2 Pandemic. Current Oncology 29: 7794-7801, No. 10, 16 Oct 2022. Available from: URL: http://doi.org/10.3390/curroncol29100616

Title: Cemiplimab
Pruritus, fatigue and worsening hypothyroidism: 2 case reports
Publication date: 01-01-2023
Publisher: Springer International Publishing
Keywords: Cutaneous Squamous Cell Carcinoma
Pruritus
Cutaneous Squamous Cell Carcinoma
Fatigue
Hypothyroidism
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-30526-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cemiplimab

Pruritus, fatigue and worsening hypothyroidism: 2 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Multiple drug

Apixaban

Metformin

Digoxin

Amphotericin-B-liposomal

Multiple drugs